Grace Therapeutics (GRCE) Cash from Financing Activities (2011 - 2026)
Grace Therapeutics' Cash from Financing Activities was $9.34 million in fiscal Q2 2027 (quarter ended Sep 30, 2026).
Grace Therapeutics (GRCE) Cash from Financing Activities (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Cash from Financing Activities was $13.38 million through Sep 30, 2026, down 2.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $3.71 million, down 73.5% from FY2025.
- Cash from Financing Activities shows a five-year compound annual growth rate of -42.6% (FY2021 to FY2026).
- In earlier fiscal years, Cash from Financing Activities was $14.03 million in FY2025 (+90.7%), $7.36 million in FY2024 and $304,000 in FY2023.
- The fiscal Q2 2027 figure marks the highest quarterly Cash from Financing Activities since fiscal Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | 9.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.34 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Jun 30, 2025 | -327,000.00 |
| Mar 31, 2025 | 14.03 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2021 | 34.68 Mn |
| Dec 31, 2020 | 19.75 Mn |
| Sep 30, 2020 | 3.43 Mn |
| Jun 30, 2020 | 1.64 Mn |
| Mar 31, 2020 | 13.18 Mn |
| Dec 31, 2019 | 7.12 Mn |
| Sep 30, 2019 | 6.60 Mn |
| Jun 30, 2019 | 34,000.00 |
| Mar 31, 2019 | 45.69 Mn |
| Dec 31, 2018 | 37.15 Mn |
| Sep 30, 2018 | -96,386.31 |
| Jun 30, 2018 | 8.09 Mn |
| Mar 31, 2018 | -28,483.35 |
Grace Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();